Year-end Sale % OFF 
Abstract
Maintenance immunosuppressive regimens in heart transplantation usually include a calcineurin inhibitor. Cyclosporine and tacrolimus are the calcineurin inhibitors used as primary immunosuppression in Colombia. However, tacrolimus is not currently cited in the National Benefit Plan, and data concerning the budget impact of tacrolimus is needed for the Colombian government to consider its inclusion. This research was undertaken to estimate the impact of the tacrolimus-mycophenolate mofetil (TAC-MMF) regimen on the Colombian third-party payer budget.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
